| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Omeprazole and sodium bicarbonate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Omeprazole and sodium bicarbonate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only omeprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only omeprazole in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Aspirin and omeprazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 40 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 40 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole (as omeprazole magnesium) 10 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Magnesium hydroxide- and omeprazole- and sodium bicarbonate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing amoxicillin and omeprazole and rifabutin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
3 |
| Amoxicillin and omeprazole and rifabutin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
3 |
| Amoxicillin- and omeprazole- and rifabutin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
3 |
| Amoxicillin and omeprazole and rifabutin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
3 |
| Omeprazole 20 mg and sodium bicarbonate 1.1 g oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.1 gram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing domperidone and omeprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing domperidone and omeprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only domperidone and omeprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Domperidone and omeprazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 10 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 10 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely omeprazole 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Omeprazole (substance) |
Inferred relationship |
Some |
1 |
FHIR